A team of UTHSC researchers has been awarded $924,000 from the Department of Defense for their work developing a new treatment for ovarian cancer. The project is a collaboration between the labs of Wei Li, PhD, distinguished professor of Pharmaceutical Sciences and director of the Drug Discovery Center in the College of Pharmacy, Junming Yue,… Read More
Repeated traumatic brain injuries (TBI) in soldiers and military personnel can cause behavioral, neurological, and cognitive effects and lead to dementia. There is currently no treatment for that type of dementia, but a $308,000 grant from the United States Department of Defense aims to help researchers at the University of Tennessee Health Science Center find… Read More
Researchers from the University of Tennessee Health Science Center have received a $500,000 grant over three years from the Department of Defense to test a novel strategy using mitochondria transplantation therapy for restoration of neuromuscular structure and function after injury. Poor or incomplete muscle repair after an injury delays or prevents normal function and can… Read More
The Department of Defense (DOD) has awarded a $1.3 million grant to researchers at the University of Tennessee Health Science Center, Memphis Veterans Affairs (VA) Medical Center, and Virginia Commonwealth University (VCU) to assist caregivers of veterans who are living with traumatic brain injury (TBI) and dementia. Linda Nichols, PhD, FGSA, FSfAA, professor in the… Read More
As the most common non-skin cancer in America, prostate cancer affects one in nine men. There are many risk factors that make some men more susceptible than others, and among those factors are race and ethnicity. Jay Fowke, PhD, MPH, chief of the Division of Epidemiology and professor in the Department of Preventive Medicine at… Read More
Anton Reiner, PhD, professor in the Departments of Anatomy & Neurobiology, and Ophthalmology in the College of Medicine at the University of Tennessee Health Science Center (UTHSC), has received $1.35 million from the U.S. Department of Defense to study the benefits of the drug Raloxifene as a therapy to help reduce visual impairment stemming from… Read More
